Abstract submission now open

1. Oral Presentation: 8 – 10 minutes, with 2 – 5 minutes for questions.
2. Poster Presentation: 
   • Format: A0 size (841mm x 1189mm or 33.1 × 46.8 inches), portrait orientation
   • Display: Hard copy, printed (may be laminated or on fabric)
   • Authors must be present at their poster during the specified time 

Please submit your abstract under one of the following categories: 

• Alternative Sampling Strategies 

• Anti-Infective Drugs 

• Clinical Toxicology/Drugs of Misuse 

• Immunosuppressive Drugs & Biomarkers 

• Pharmacometrics 

• Pharmacogenetics 

• TDM of Biologics 

• TDM in Oncology 

• Toxicology & Environmental Health 

• Other

These categories reflect the core IATDMCT Scientific Committees, however submissions from all areas of TDM and Clinical Toxicology are welcome.  

1. Language: English only 
2. Title: Maximum 12 words 
3. Abstract length: 250 words or less (excluding title, author names, affiliations) 
4. Text format:  
   • Use sentence case (not ALL CAPS) 
   • Check spelling and grammar carefully 
5. Content restrictions:  
   • No figures, graphs, images, or diagrams 
   • Describe unpublished work only 
6. Structure: Use these subheaders:  
   • Background 
   • Aims
   • Methods 
   • Results 
   • Conclusions 
   • Keywords (up to 6, separated by commas)
   
   Leave a blank line after each section. 

Abstracts must include sufficient data so that the reader can understand the experimental design, methods, results, and any conclusions that might be drawn from the study. The text should be as informative as possible. Statements such as “The results will be discussed” are not acceptable and will likely result in rejection. 

1. Create an account on the abstract submission portal.
2. Enter your abstract directly into the provided text box. 
3. Do not include title, author names, or affiliations in the abstract text box. These are captured in separate fields of the form. 
4. You will receive a confirmation email after submission.

    

If you don’t receive a confirmation email, please check your spam folder, then contact iatdmct2025@expertevents.com.au. 

All abstracts undergo a review process. Reviewers consider: 

• Scientific merit and originality 

• Relevance to therapeutic drug monitoring and/or clinical toxicology 

• Relevance to the congress theme (Creative solutions for global challenges) 

• Methodology and study design 

• Quality of analytical approach 

• Clarity of objectives and hypotheses 

• Potential impact on clinical practice or future research 

• Practical applicability of results 

• Presentation quality (structure, language, adherence to abstract guidelines) 

To be considered for this award, please provide the following information in the Applicant Details section: 

1. Check the appropriate box 
2. Provide your birth date

Please review eligibility criteria and guidelines on the IATDMCT website.